{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:11:19Z","timestamp":1791191479706,"version":"4.1.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.tips.2012.09.004","type":"journal-article","created":{"date-parts":[[2012,10,18]],"date-time":"2012-10-18T06:12:50Z","timestamp":1350540770000},"page":"669-684","source":"Crossref","is-referenced-by-count":109,"title":["Synapse dysfunction in autism: a molecular medicine approach to drug discovery in neurodevelopmental disorders"],"prefix":"10.1016","volume":"33","author":[{"given":"Will","family":"Spooren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Lindemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirvan","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Santarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2012.09.004_bib0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.tips.2012.09.004_bib0010","series-title":"ICD-10: Version 2010","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.tips.2012.09.004_bib0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4103\/0256-4947.65261","article-title":"Autism spectrum disorders","volume":"30","author":"Faras","year":"2010","journal-title":"Ann. Saudi Med."},{"key":"10.1016\/j.tips.2012.09.004_bib0020","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1542\/peds.2007-2361","article-title":"Identification and evaluation of children with autism spectrum disorders","volume":"120","author":"Johnson","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.tips.2012.09.004_bib0025","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(09)61376-3","article-title":"Autism","volume":"374","author":"Levy","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2012.09.004_bib0030","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/1469-7610.00022","article-title":"Practitioner review: diagnosis of autism spectrum disorder in 2- and 3-year-old children","volume":"43","author":"Charman","year":"2002","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.tips.2012.09.004_bib0035","first-page":"127","article-title":"Autism: recognising the signs in young children","volume":"8","author":"Humphries","year":"1998","journal-title":"Prof. Care Mother Child"},{"key":"10.1016\/j.tips.2012.09.004_bib0040","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.pcl.2008.07.005","article-title":"Autism: definition, neurobiology, screening, diagnosis","volume":"55","author":"Rapin","year":"2008","journal-title":"Pediatr. Clin. North Am."},{"key":"10.1016\/j.tips.2012.09.004_bib0045","first-page":"412","article-title":"Early identification of autism","volume":"46","author":"Chakrabarti","year":"2009","journal-title":"Indian Pediatr."},{"key":"10.1016\/j.tips.2012.09.004_bib0050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1005592401947","article-title":"The autism diagnostic observation schedule \u2013 generic: a standard measure of social and communication deficits associated with the spectrum of autism","volume":"30","author":"Lord","year":"2000","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.tips.2012.09.004_bib0055","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF02212936","article-title":"Autism diagnostic interview: a standardized investigator-based instrument","volume":"19","author":"Le Couteur","year":"1989","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.tips.2012.09.004_bib0060","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF00584048","article-title":"Epidemiology of autistic conditions in young children","volume":"1","author":"Lotter","year":"1966","journal-title":"Soc. Psychiatry"},{"key":"10.1016\/j.tips.2012.09.004_bib0065","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(06)69041-7","article-title":"Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP)","volume":"368","author":"Baird","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2012.09.004_bib0070","doi-asserted-by":"crossref","first-page":"e1001081","DOI":"10.1371\/journal.pbio.1001081","article-title":"Why are autism spectrum conditions more prevalent in males?","volume":"9","author":"Baron-Cohen","year":"2011","journal-title":"PLoS Biol."},{"key":"10.1016\/j.tips.2012.09.004_bib0075","first-page":"1","article-title":"Prevalence of autism spectrum disorders \u2013 Autism and Developmental Disabilities Monitoring Network, United States, 2006","volume":"58","author":"Rice","year":"2009","journal-title":"MMWR Surveill. Summ."},{"key":"10.1016\/j.tips.2012.09.004_bib0080","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/1362361309104246","article-title":"Economic cost of autism in the UK","volume":"13","author":"Knapp","year":"2009","journal-title":"Autism"},{"key":"10.1016\/j.tips.2012.09.004_bib0085","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1542\/peds.2007-2362","article-title":"Management of children with autism spectrum disorders","volume":"120","author":"Myers","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.tips.2012.09.004_bib0090","series-title":"Therapies for Children with Autism Spectrum Disorders","author":"Warren","year":"2011"},{"key":"10.1016\/j.tips.2012.09.004_bib0095","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.cell.2012.02.039","article-title":"CNVs: harbingers of a rare variant revolution in psychiatric genetics","volume":"148","author":"Malhotra","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.tips.2012.09.004_bib0100","doi-asserted-by":"crossref","first-page":"17076","DOI":"10.1073\/pnas.1114042108","article-title":"Dosage-dependent phenotypes in models of 16p11.2 lesions found in autism","volume":"108","author":"Horev","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2012.09.004_bib0105","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature10945","article-title":"De novo mutations revealed by whole-exome sequencing are strongly associated with autism","volume":"485","author":"Sanders","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.tips.2012.09.004_bib0110","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/nn.2924","article-title":"The conundrums of understanding genetic risks for autism spectrum disorders","volume":"14","author":"State","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2012.09.004_bib0115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.gde.2009.04.004","article-title":"Genetic advances in autism: heterogeneity and convergence on shared pathways","volume":"19","author":"Bill","year":"2009","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.tips.2012.09.004_bib0120","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s11910-009-0029-2","article-title":"Genetics of autism spectrum disorders","volume":"9","author":"Kumar","year":"2009","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.tips.2012.09.004_bib0125","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2012.102","article-title":"Translational approaches to the biology of autism: false dawn or a new era?","author":"Ecker","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tips.2012.09.004_bib0130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng1136","article-title":"Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism","volume":"34","author":"Jamain","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2012.09.004_bib0135","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrg2346","article-title":"Advances in autism genetics: on the threshold of a new neurobiology","volume":"9","author":"Abrahams","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tips.2012.09.004_bib0140","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1523\/JNEUROSCI.4354-04.2005","article-title":"Shank expression is sufficient to induce functional dendritic spine synapses in aspiny neurons","volume":"25","author":"Roussignol","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2012.09.004_bib0145","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1523\/JNEUROSCI.3032-07.2008","article-title":"Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1","volume":"28","author":"Hung","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2012.09.004_bib0150","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.tins.2009.04.003","article-title":"The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders","volume":"32","author":"Betancur","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tips.2012.09.004_bib0155","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1056\/NEJMoa0802828","article-title":"A functional genetic link between distinct developmental language disorders","volume":"359","author":"Vernes","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2012.09.004_bib0160","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.1157657","article-title":"Identifying autism loci and genes by tracing recent shared ancestry","volume":"321","author":"Morrow","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.tips.2012.09.004_bib0165","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature07999","article-title":"Common genetic variants on 5p14.1 associate with autism spectrum disorders","volume":"459","author":"Wang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.tips.2012.09.004_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1461145708009127","article-title":"Association of the neuronal cell adhesion molecule (NRCAM) gene variants with autism","volume":"12","author":"Marui","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.tips.2012.09.004_bib0175","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1136\/jmg.2008.057596","article-title":"Detection of known and novel genomic rearrangements by array based comparative genomic hybridisation: deletion of ZNF533 and duplication of CHARGE syndrome genes","volume":"45","author":"Monfort","year":"2008","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.tips.2012.09.004_bib0180","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev.neuro.25.112701.142909","article-title":"A decade of molecular studies of fragile X syndrome","volume":"25","author":"O\u2019Donnell","year":"2002","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.tips.2012.09.004_bib0185","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","article-title":"FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism","volume":"146","author":"Darnell","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.tips.2012.09.004_bib0190","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/1073858409333075","article-title":"The state of synapses in fragile X syndrome","volume":"15","author":"Pfeiffer","year":"2009","journal-title":"Neuroscientist"},{"key":"10.1016\/j.tips.2012.09.004_bib0195","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-med-061109-134644","article-title":"Toward fulfilling the promise of molecular medicine in fragile X syndrome","volume":"62","author":"Krueger","year":"2011","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.tips.2012.09.004_bib0200","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.molmed.2010.08.005","article-title":"Potential therapeutic interventions for fragile X syndrome","volume":"16","author":"Levenga","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tips.2012.09.004_bib0205","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/cap.2006.16.525","article-title":"Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial","volume":"16","author":"Berry-Kravis","year":"2006","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.tips.2012.09.004_bib0210","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/jmg.2008.061796","article-title":"Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model","volume":"46","author":"Bilousova","year":"2009","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.tips.2012.09.004_bib0215","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.tins.2004.04.009","article-title":"The mGluR theory of fragile X mental retardation","volume":"27","author":"Bear","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tips.2012.09.004_bib0220","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.nbd.2008.04.002","article-title":"Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice","volume":"31","author":"de Vrij","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tips.2012.09.004_bib0225","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.neuron.2007.12.001","article-title":"Correction of fragile X syndrome in mice","volume":"56","author":"Dolen","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2012.09.004_bib0230","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuron.2012.03.009","article-title":"Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice","volume":"74","author":"Michalon","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2012.09.004_bib0235","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: from clinic to neurobiology","volume":"56","author":"Chahrour","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2012.09.004_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20110648","article-title":"MeCP2 and Rett syndrome: reversibility and potential avenues for therapy","volume":"439","author":"Gadalla","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.tips.2012.09.004_bib0245","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1146\/annurev-cellbio-092910-154121","article-title":"The role of MeCP2 in the brain","volume":"27","author":"Guy","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.tips.2012.09.004_bib0250","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1523\/JNEUROSCI.0169-11.2011","article-title":"Complexities of Rett syndrome and MeCP2","volume":"31","author":"Samaco","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2012.09.004_bib0255","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archneurol.2011.149","article-title":"Rett syndrome: exploring the autism link","volume":"68","author":"Percy","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.tips.2012.09.004_bib0260","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1152\/jn.00826.2007","article-title":"Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome","volume":"99","author":"Medrihan","year":"2008","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.tips.2012.09.004_bib0265","doi-asserted-by":"crossref","first-page":"12560","DOI":"10.1073\/pnas.0506071102","article-title":"Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome","volume":"102","author":"Dani","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2012.09.004_bib0270","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neulet.2008.09.045","article-title":"Tyrosine hydroxylase deficit in the chemoafferent and the sympathoadrenergic pathways of the Mecp2 deficient mouse","volume":"447","author":"Roux","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tips.2012.09.004_bib0275","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.nbd.2005.07.005","article-title":"Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome","volume":"21","author":"Asaka","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tips.2012.09.004_bib0280","first-page":"28","article-title":"Synaptic determinants of Rett syndrome","volume":"2","author":"Boggio","year":"2010","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.tips.2012.09.004_bib0285","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.tips.2012.09.004_bib0290","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.0610593104","article-title":"Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2","volume":"104","author":"Giacometti","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2012.09.004_bib0295","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/hmg\/ddh282","article-title":"Mild overexpression of MeCP2 causes a progressive neurological disorder in mice","volume":"13","author":"Collins","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2012.09.004_bib0300","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","article-title":"The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression","volume":"49","author":"Chang","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2012.09.004_bib0305","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1073\/pnas.0812394106","article-title":"Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice","volume":"106","author":"Tropea","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2012.09.004_bib0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2008.12.051","article-title":"Neurofibromatosis type 1","volume":"61","author":"Boyd","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.tips.2012.09.004_bib0315","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.tips.2012.09.004_bib0320","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.cub.2005.09.043","article-title":"The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1","volume":"15","author":"Li","year":"2005","journal-title":"Curr. Biol."},{"key":"10.1016\/j.tips.2012.09.004_bib0325","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature711","article-title":"Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1","volume":"415","author":"Costa","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.tips.2012.09.004_bib0330","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2012.09.004_bib0335","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/1531-8249(200101)49:1<67::AID-ANA10>3.0.CO;2-L","article-title":"Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers","volume":"49","author":"White","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2012.09.004_bib0340","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","article-title":"Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function","volume":"28","author":"Meikle","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2012.09.004_bib0345","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1788","article-title":"Reversal of learning deficits in a Tsc2+\/\u2212 mouse model of tuberous sclerosis","volume":"14","author":"Ehninger","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2012.09.004_bib0350","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature10658","article-title":"Mutations causing syndromic autism define an axis of synaptic pathophysiology","volume":"480","author":"Auerbach","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.tips.2012.09.004_bib0355","unstructured":"Ehninger, D. From genes to cognition in tuberous sclerosis: implications for mTOR inhibitor-based treatment approaches. Neuropharmacology, (in press)"},{"key":"10.1016\/j.tips.2012.09.004_bib0360","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.molmed.2010.10.002","article-title":"Rapamycin for treating tuberous sclerosis and autism spectrum disorders","volume":"17","author":"Ehninger","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tips.2012.09.004_bib0365","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/jmg.2004.024646","article-title":"Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations","volume":"42","author":"Butler","year":"2005","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.tips.2012.09.004_bib0370","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.conb.2005.01.002","article-title":"Transcriptional control of cognitive development","volume":"15","author":"Hong","year":"2005","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.tips.2012.09.004_bib0375","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fncir.2011.00009","article-title":"Delta protocadherin 10 is regulated by activity in the mouse main olfactory system","volume":"5","author":"Williams","year":"2011","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.tips.2012.09.004_bib0380","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ajhg.2008.01.013","article-title":"SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndrome","volume":"82","author":"Gilfillan","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tips.2012.09.004_bib0385","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/ejhg.2009.67","article-title":"Angelman syndrome (AS, MIM 105830)","volume":"17","author":"Van","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.tips.2012.09.004_bib0390","doi-asserted-by":"crossref","first-page":"e14534","DOI":"10.1371\/journal.pone.0014534","article-title":"DIA1R is an X-linked gene related to deleted in autism-1","volume":"6","author":"Aziz","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2012.09.004_bib0395","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.tins.2011.03.004","article-title":"Presynaptic function in health and disease","volume":"34","author":"Waites","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tips.2012.09.004_bib0400","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.biopsych.2003.10.006","article-title":"Microanatomy of dendritic spines: emerging principles of synaptic pathology in psychiatric and neurological disease","volume":"55","author":"Blanpied","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tips.2012.09.004_bib0405","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1101\/gad.1973910","article-title":"Eph\/ephrin molecules \u2013 a hub for signaling and endocytosis","volume":"24","author":"Pitulescu","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.tips.2012.09.004_bib0410","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng1933","article-title":"Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders","volume":"39","author":"Durand","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2012.09.004_bib0415","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/522590","article-title":"Contribution of SHANK3 mutations to autism spectrum disorder","volume":"81","author":"Moessner","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tips.2012.09.004_bib0420","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.tcb.2011.07.003","article-title":"Postsynaptic ProSAP\/Shank scaffolds in the cross-hair of synaptopathies","volume":"21","author":"Grabrucker","year":"2011","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.tips.2012.09.004_bib0425","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2040-2392-1-15","article-title":"Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication","volume":"1","author":"Bozdagi","year":"2010","journal-title":"Mol. Autism"},{"key":"10.1016\/j.tips.2012.09.004_bib0430","doi-asserted-by":"crossref","first-page":"6525","DOI":"10.1523\/JNEUROSCI.6107-11.2012","article-title":"Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice","volume":"32","author":"Yang","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2012.09.004_bib0435","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2010.09.038","article-title":"EphB-mediated degradation of the RhoA GEF ephexin5 relieves a developmental brake on excitatory synapse formation","volume":"143","author":"Margolis","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.tips.2012.09.004_bib0440","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuron.2010.03.017","article-title":"Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2","volume":"66","author":"Pfeiffer","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2012.09.004_bib0445","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11910-010-0104-8","article-title":"Synapse pathology in psychiatric and neurologic disease","volume":"10","author":"van Spronsen","year":"2010","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.tips.2012.09.004_bib0450","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuron.2007.08.018","article-title":"MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number","volume":"56","author":"Chao","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2012.09.004_bib0455","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1523\/JNEUROSCI.2623-05.2006","article-title":"Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome","volume":"26","author":"Moretti","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2012.09.004_bib0460","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nbd.2007.04.005","article-title":"Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons","volume":"27","author":"Smrt","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tips.2012.09.004_bib0465","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.nbd.2009.05.001","article-title":"Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations","volume":"35","author":"Chapleau","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tips.2012.09.004_bib0470","doi-asserted-by":"crossref","first-page":"297153","DOI":"10.1155\/2011\/297153","article-title":"Alterations of GABAergic signaling in autism spectrum disorders","volume":"2011","author":"Pizzarelli","year":"2011","journal-title":"Neural Plast."},{"key":"10.1016\/j.tips.2012.09.004_bib0475","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrn1327","article-title":"Homeostatic plasticity in the developing nervous system","volume":"5","author":"Turrigiano","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tips.2012.09.004_bib0480","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","article-title":"Model of autism: increased ratio of excitation\/inhibition in key neural systems","volume":"2","author":"Rubenstein","year":"2003","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.tips.2012.09.004_bib0485","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1010715619091","article-title":"Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism","volume":"31","author":"Hussman","year":"2001","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.tips.2012.09.004_bib0490","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nrn919","article-title":"Is there more to GABA than synaptic inhibition?","volume":"3","author":"Owens","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tips.2012.09.004_bib0495","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrn2188","article-title":"Development of GABA innervation in the cerebral and cerebellar cortices","volume":"8","author":"Huang","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tips.2012.09.004_bib0500","doi-asserted-by":"crossref","first-page":"10372","DOI":"10.1523\/JNEUROSCI.19-23-10372.1999","article-title":"The establishment of GABAergic and glutamatergic synapses on CA1 pyramidal neurons is sequential and correlates with the development of the apical dendrite","volume":"19","author":"Tyzio","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2012.09.004_bib0505","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nature07456","article-title":"Neuroligins and neurexins link synaptic function to cognitive disease","volume":"455","author":"S\u00fcdhof","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.tips.2012.09.004_bib0510","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.braindev.2010.04.010","article-title":"Epilepsy and autism spectrum disorders: are there common developmental mechanisms?","volume":"32","author":"Brooks-Kayal","year":"2010","journal-title":"Brain Dev."},{"key":"10.1016\/j.tips.2012.09.004_bib0515","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/MOP.0b013e32834c7f1a","article-title":"Advances in understanding fragile X syndrome and related disorders","volume":"23","author":"Rooms","year":"2011","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.tips.2012.09.004_bib0520","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.neuron.2009.08.023","article-title":"Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin","volume":"63","author":"Poulopoulos","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2012.09.004_bib0525","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic glutamate receptors: physiology, pharmacology, and disease","volume":"50","author":"Niswender","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.tips.2012.09.004_bib0530","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1073\/pnas.122205699","article-title":"Altered synaptic plasticity in a mouse model of fragile X mental retardation","volume":"99","author":"Huber","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2012.09.004_bib0535","doi-asserted-by":"crossref","first-page":"131ra51","DOI":"10.1126\/scitranslmed.3003501","article-title":"Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism","volume":"4","author":"Silverman","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tips.2012.09.004_bib0540","doi-asserted-by":"crossref","first-page":"e26077","DOI":"10.1371\/journal.pone.0026077","article-title":"mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism","volume":"6","author":"Mehta","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2012.09.004_bib0545","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/01.fbp.0000081783.35927.8f","article-title":"Insight into the function of group I and group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders","volume":"14","author":"Spooren","year":"2003","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.tips.2012.09.004_bib0550","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1124\/jpet.111.185660","article-title":"CTEP: a novel, potent, long-acting, and orally bioavailable metabotropic glutamate receptor 5 inhibitor","volume":"339","author":"Lindemann","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2012.09.004_bib0555","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2010.10.017","article-title":"Ephecting excitatory synapse development","volume":"143","author":"Dalva","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.tips.2012.09.004_bib0560","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.publhealth.28.021406.144007","article-title":"The epidemiology of autism spectrum disorders","volume":"28","author":"Newschaffer","year":"2007","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.tips.2012.09.004_bib0565","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(03)14471-6","article-title":"Autism","volume":"362","author":"Volkmar","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2012.09.004_bib0570","series-title":"The Economic Consequences of Autism in the UK","author":"Knapp","year":"2007"},{"key":"10.1016\/j.tips.2012.09.004_bib0575","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1517\/14728214.2010.487860","article-title":"Emerging drugs for the treatment of symptoms associated with autism spectrum disorders","volume":"15","author":"Wink","year":"2010","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.tips.2012.09.004_bib0580","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/DBP.0b013e3181ee3833","article-title":"Emerging pharmacotherapies for neurodevelopmental disorders","volume":"31","author":"Wetmore","year":"2010","journal-title":"J. Dev. Behav. Pediatr."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614712001629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614712001629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T20:02:51Z","timestamp":1562270571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614712001629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":116,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0165614712001629"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2012.09.004","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}